Benefits of SMA newborn screening shown in pilot program

The findings of a state-wide pilot newborn screening program for spinal muscular atrophy (SMA) were presented at ICNA/CNS 2020.

Dr Kathryn Elkins from Emory University in Atlanta, Georgia, USA, led a study investigating outcomes in the infants with SMA detected by the newborn screening program in Georgia (launched as a pilot in February 2019).

In the first year, 14 infants were found to be positive for SMA out of a total of 170,000 live-born infants screened – an incidence of 1 in 12,142 births.

Dr Elkins reported that:

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.